Human Phenotype Project

AI-powered precision from molecular signatures

Israel

Human Phenotype Project is a 25-year longitudinal research initiative launched in 2018. It collects deep-phenotype multi-omics datasets and applies AI-driven analytics to identify novel biomarkers, personalize treatments, and accelerate drug development.

Shareable draft

Check out Human Phenotype Project on @MedStartr Today Human Phenotype Project is a 25-year longitudinal research initiative launched in 2018. It collects deep-phenotype multi-omics datasets and applies AI-driven analytics to identify novel biomarkers, personalize treatments, and accelerate drug development. #Type2Diabetes #Aging #CardiovascularDisease #NeurologicalDisorders #MentalBehavioralHealth #ObesityOverweight #CardiometabolicDiseases #RespiratoryDiseases #MetabolicDiseases #DigestiveDiseases #PrecisionMedicineDiagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/v0CcTlW-Gro

Get Involved in Human Phenotype Project

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

How We Help

Problem Statement

The lack of comprehensive, longitudinal multi-omics data hinders the identification of novel biomarkers, personalization of treatments, and acceleration of drug development.

Core Technology

AI-driven analytics

Key Differentiators

deep-phenotype multi-omics datasets across genomics, proteomics, metabolomics, imaging, and clinical data; 25-year longitudinal research initiative; Proprietary datasets include 28,000+ enrolled participants with 13,000+ completing initial visits

Clinical Focus

novel biomarkers; personalized treatments; drug development

Company Info

Business Model: Platform
Founded: 2018
Website: humanphenotypeproject.org/

Disease Areas

Type 2 Diabetes Aging Cardiovascular Disease Neurological Disorders Mental Health Obesity & Overweight Cardiometabolic Diseases Respiratory Diseases Metabolic Diseases Digestive Diseases

Technologies

ProteomicsMetabolomicsImaging & VisualizationGenomicsAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Nature Medicine published 2025; AI outperforms standard care in disease prediction; GluFormer and COMPRER models validated on cardiovascular and metabolic disease; funded by Minerva foundation, ERC, and Israel Science Foundation

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Human Phenotype Project?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.